CGA
ARKG icon

Crescent Grove Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Crescent Grove Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Hold
34,508
– – 0.12% 120
2026
Q1 		$912K Sell
34,508
-4,481
-11% -$131K 0.09% 140
2025
Q4 		$1.13M Buy
38,989
+2,451
+7% +$73.6K 0.1% 121
2025
Q3 		$1.01M Sell
36,538
-57
-0.2% -$1.44K 0.1% 119
2025
Q2 		$891K Buy
36,595
+2,056
+6% +$45.1K 0.09% 122
2025
Q1 		$717K Buy
34,539
+4,030
+13% +$101K 0.07% 131
2024
Q4 		$718K Buy
30,509
+1,595
+6% +$39.3K 0.07% 133
2024
Q3 		$740K Buy
28,914
+460
+2% +$11.7K 0.08% 136
2024
Q2 		$668K Buy
28,454
+4,660
+20% +$118K 0.07% 139
2024
Q1 		$684K Buy
23,794
+2,009
+9% +$60.4K 0.07% 143
2023
Q4 		$715K Sell
21,785
-3
-0% -$82 0.08% 138
2023
Q3 		$607K Sell
21,788
-274
-1% -$8.96K 0.08% 150
2023
Q2 		$752K Sell
22,062
-534
-2% -$16.8K 0.08% 129
2023
Q1 		$679K Hold
22,596
– – 0.08% 139
2022
Q4 		$638K Sell
22,596
-927
-4% -$29.4K 0.07% 153
2022
Q3 		$773K Sell
23,523
-161
-0.7% -$5.91K 0.09% 122
2022
Q2 		$746K Buy
23,684
+4,039
+21% +$141K 0.08% 128
2022
Q1 		$902K Buy
19,645
+860
+5% +$41K 0.09% 120
2021
Q4 		$1.15M Sell
18,785
-642
-3% -$44.4K 0.11% 102
2021
Q3 		$1.45M Buy
19,427
+1,916
+11% +$161K 0.15% 79
2021
Q2 		$1.62M Sell
17,511
-8,169
-32% -$695K 0.17% 70
2021
Q1 		$2.28M Buy
25,680
+17,094
+199% +$1.7M 0.27% 50
2020
Q4 		$801K Buy
8,586
+5,101
+146% +$406K 0.1% 83
2020
Q3 		$222K Buy
+3,485
New +$204K 0.04% 151

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Crescent Grove Advisors's ARKG Position: Q2 2026 in Review

Crescent Grove Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 34,508 shares worth $1.45M. The position accounts for 0.12% of the portfolio, ranked #120.

Crescent Grove Advisors first reported a position in ARKG in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.28M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Crescent Grove Advisors held 34,508 shares of ARK Genomic Revolution ETF worth $1.45M as of Q2 2026.
  • Crescent Grove Advisors left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.12% of Crescent Grove Advisors's portfolio in Q2 2026, its #120 holding.
  • Crescent Grove Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 24 quarters since.
  • Crescent Grove Advisors's ARK Genomic Revolution ETF position peaked at $2.28M in Q1 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.